Anticoagulant Thrombins
- 30 November 1998
- journal article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 8 (8), 340-350
- https://doi.org/10.1016/s1050-1738(98)00030-9
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Discovery and Development of the Novel Potent Orally Active Thrombin Inhibitor N-(9-Hydroxy-9-fluorenecarboxy)prolyl trans-4-Aminocyclohexylmethyl Amide (L-372,460): Coapplication of Structure-Based Design and Rapid Multiple Analogue Synthesis on Solid SupportJournal of Medicinal Chemistry, 1998
- Selective Loss of Fibrinogen Clotting in a Loop-less ThrombinPublished by Elsevier ,1997
- Rational engineering of activity and specificity in a serine proteaseNature Biotechnology, 1997
- Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases.Proceedings of the National Academy of Sciences, 1996
- Enhanced Protein C Activation and Inhibition of Fibrinogen Cleavage by a Thrombin ModulatorScience, 1996
- An allosteric switch controls the procoagulant and anticoagulant activities of thrombin.Proceedings of the National Academy of Sciences, 1995
- Partial characterization of vertebrate prothrombin cDNAs: amplification and sequence analysis of the B chain of thrombin from nine different species.Proceedings of the National Academy of Sciences, 1992
- The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationshipsProtein Science, 1992
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991
- Human .alpha.- to .zeta.-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retainedBiochemistry, 1990